A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years

NCT06210737 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

621

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

BIOLOGICAL: PCV13
BIOLOGICAL: PCV13
BIOLOGICAL: PCV13
BIOLOGICAL: PCV13

Sponsor

Beijing Minhai Biotechnology Co., Ltd